hers
Hims & Hers Health, Inc. (HIMS) Stock: Peptides+ Launch Expands Healthcare Services
TLDR HIMS stock falls 2.93% to $17.04 despite the launch of its Peptides+ service. Peptides+ debuts with five treatments guided by licensed medical providers. H…





